Unser Team sucht Verstärkung: Medizinisch-Technische/r Assistent/in (MTLA), Vollzeit | April 28, 2017
Sie haben Interesse an abwechslungsreichen Tätigkeiten in einem engagierten Team mit netten Kolleginnen und Kollegen?
Gesucht: Medizinisch-Technische/r Assistent/in (MTLA)
BCA-lab ist ein hochspezialisierter Labordienstleister, der strukturell zur BCA-clinic in Augsburg gehört, ein ärztlich geleitetes Unternehmen. Unsere Kunden profitieren von der Symbiose zwischen dem Labor und den therapeutisch tätigen Ärzten. Das Labor hat sich seit seiner Gründung 2006 kontinuierlich weiter entwickelt und spezialisiert. Seit 3 Jahren gibt es auch ein Forschungslabor. Zu den Einsendern und Kooperationspartnern gehören Kliniken, Labore und Arztpraxen aus vielen Ländern der Welt.
Die Weiterentwicklung von diagnostischen und therapeutischen Methoden für die Behandlung von Multi-System-Erkrankungen soll in den nächsten Jahren durch die Forschungsarbeit im Labor intensiviert werden.
Das Servicelabor BCA-lab ist durch die Deutsche Akkreditierungsstelle DAkkS nach DIN EN ISO 15189:2014 offiziell für den Elispot, die CD57+Zellen sowie den ELISA und IFT für die Diagnostik Zecken-übertragener Erkrankungen/Ko-Infektionen akkreditiert.
- Abgeschlossene Berufsausbildung zur staatlich anerkannten MTLA, möglichst mit Berufserfahrung
- Kenntnisse und Erfahrungen mit den Labormethoden: ELISA, IFT, Immunoblot IFT, Durchflusszytometrie, Elispot
- Gute englische Sprachkenntnisse in Wort und Schrift
- Dokumentationen im Rahmen des Qualitätsmanagements
- Bereitschaft zur Wochenend- und Feiertagsarbeit
- Kenntnisse im Umgang mit gängigen EDV-Anwendungen, Laborsoftware MELOS
- Teamfähigkeit, Belastbarkeit, hohes Engagement und ein verantwortungsbewusstestes und selbständiges Arbeiten
Der Einsatz erfolgt sowohl direkt im Labor (Probenvorbereitung, Messung von Laborparametern, technische Validierung, Dokumentation, QM) als auch in der Verwaltung des Labors (Bearbeitung von Anfragen, bspw. per E-Mail und telefonisch, Bestellwesen, Zuarbeiten zur Abrechnung).
- abwechslungsreiche und herausfordernde Tätigkeit mit 40 Wochenstunden, unbefristeter Arbeitsvertrag
- die Stelle ist ab sofort zu vergeben
- angemessenes Entgelt
- ein engagiertes und professionelles Team
Bitte senden Sie Ihre vollständigen Bewerbungsunterlagen per E-Mail an:
Für fachliche Rückfragen steht Ihnen Frau Stefanie Beck unter Telefon (0821) 455 982 -10 zur Verfügung!
Merry Christmas and a Happy New Year | December 19, 2016
Our laboratory is closed at the following public holidays:
26th December 2016 and 6th January 2017
Otherwise we are open for business Monday to Friday, 8am to 5pm.
Einblicke: Der Infotag BCA-clinic & BCA-lab | October 11, 2016
Am 29. Oktober 2016 in der Zeit von 14 Uhr bis 17 Uhr veranstaltete die BCA-clinic Betriebs GmbH & Co. KG anlässlich ihres 10-jährigen Bestehens einen Infotag.
Ein spannender Tag in BCA-clinic und BCA-labor: 104 Besucher sind zu unserem Infotag in die Morellstraße gekommen. An Stationen konnten sie sich unterhaltsam über Zecken und Tests informieren, Zecken-entfernen üben und ein Quiz absolvieren.
Dr. Nicolaus und Infectolab-Vet Tierarzt Dr. Wolff erläuterten in Vorträgen Wissenswertes über “Borreliose & Mensch” und “Borreliose & Tier”.
Außerdem freuen wir uns sehr, dass wir Frau Brenner, die Leiterin der wiederbelebten Augsburger Borreliose-Selbsthilfegruppe des Borreliose und FSME Bund Deutschland e.V. mit einer Präsentation bei uns zu Gast haben durften.
Vielen herzlichen Dank allen Mitwirkenden und Besuchern für die spannenden Diskussionen und das rege Interesse! Es war uns eine große Freude.
Statement of the BCA-clinic on the documentary entitled “Snyd eller Borrelia” of the Danish channel TV2 on 29.09.2016 | October 01, 2016
As we feared, the coverage of the Danish TV2 channel is grossly tendentious. In our view, it had unfortunately been orchestrated in a way that is purposefully unilateral against the treatment of patients suffering from late stages of Lyme borreliosis in Germany. Voices from several patients, who had been interviewed and now complain that the original content of their answers was reported in a completely distorted manner, are a clear indication for this.
The testing procedures offered by BCA have proven their worth in Germany over many years in terms of detection and treatment of infections transmitted by ticks, and have been examined in numerous studies extensively and transparently documented on the BCA website. Strict attention is paid to the fact that all tests used in the BCA laboratory are of the respective highest available quality. Beyond pure detection, the cellular tests of the BCA additionally aim at providing the treating physicians with further diagnostic means, particularly with respect to the degree of activity of the Borrelia bacteria and the degree of inflammation. The BCA Research Department is working on a consistent further development of these tools.
A random sample covering individual weeks, which had been taken over several months, recently confirmed that even in the case of the BCA cellular tests, less than 15 percent of the samples on average had shown a clearly positive result ̶ despite the basic population which had been preselected by the physicians as cases in which borreliosis may be suspected. With a representative sample from a basic population and/or total population which has not been preselected, this value would even be much lower.
Apart from that, the way of reasoning of the documentary is in no way acceptable from our viewpoint. It is being suggested that a great number of blood samples had been tested in the BCA laboratory and found to be positive. Those who were present during the shooting merely remember two test results which were presented, and a verification of the names announced in the documentary resulted in no further hits. In addition, according to the documents presented by the team of reporters, one of the two samples was particularly strongly positive for Bartonella ̶ a frequent co-infection which, as far as we know, is not even included in the Scandinavian standard tests ̶ and therefore could never be positive in the cited Danish comparative test.
In both cases, the serological tests carried out by the BCA were negative. Since these serological tests are normally offered as the only procedure in Denmark, it is simply natural that the Danish comparative test showed negative results, assuming that merely the test usual in Denmark had been performed. Those who have ever dealt with the topic of Borrelia testing know the problem that the weak point of the serological tests is deemed to be precisely the fact that their result is wrongly negative in certain stages of the infection, even if symptoms clearly exist, which leads to the infection being overlooked.
Besides that, as explained, laboratory test results are never the sole basis of a borreliosis diagnosis but serve as a laboratory or work diagnosis, as Dr. Nicolaus is correctly cited in the documentary.
In this context, it is important that the selection of the requested tests is made jointly by the physician and the patient in accordance with the symptoms and the questioning inferred therefrom. In the process, all serological and cellular test results are only ever sub-elements of the specific diagnosis of the individual case. This at least was correctly reflected in the documentary. Only in very few cases, Borrelia in a person’s body finally lead to the Lyme disease or Lyme borreliosis. Then, it is the type and the severity of the symptoms that are decisive for a treatment and for the duration and type of the recommended treatment, but never a mere test result. Physicians treat ill patients, they do not treat tests. Lyme borreliosis is and continues to be a clinical diagnosis. We assure that the false patient in the documentary mentioned clearly more symptoms and further indications for borreliosis than it is being suggested here. Owing to medical confidentiality, we are unfortunately unable to publish the relevant documentation – even in the present case of an eminently massive and libellous attack.
Concerning the difference between clinical and laboratory diagnosis: this may be difficult for some to understand, but every treating physician who receives such a laboratory diagnosis knows this difference and acts accordingly. In addition, the BCA provides advice to treating external physicians as well if these have problems interpreting the test results. However, our laboratory currently always performs tests irrespective of whether it would be possible to mark the difference between “Borrelia” and “Lyme borreliosis” more strongly in order to ensure to an even greater extent that even a person who is not an English native speaker can recognize the difference immediately.
Furthermore, we point out as follows in light of recent events: the BCA-clinic does not offer dark-field microscopy, and therapy recommendations are never made unless a patient has personally consulted the treating physicians of the clinic.
Of course, we deeply regret that the much larger number of extremely satisfied, healed or very largely healed patients of the BCA-clinic did not get a chance at all to speak in the documentary. Even after the “attack”, using a hidden camera, falsified patients inventing stories, and pictures of alleged patients whom Dr. Nicolaus did not even know personally but who were dramatically imposed on us, we had offered the reporters on several occasions to support them in establishing such contacts. Obviously, nobody was interested in giving these patients the chance to express their views as well.
Your BCA Team
(Deutsch) Verstärkung gesucht! | July 07, 2016
Für unser Servicelabor suchen wir eine/n neue/n Mitarbeiter/in (MTLA), in Teilzeit oder Vollzeit. Die detaillierte Ausschreibung finden Sie hier als Download.
Für Rückfragen wenden Sie sich bitte an Frau Stefanie Beck, Tel.: 0821 455 982 -0. Ihre vollständigen Bewerbungsunterlagen senden Sie an: firstname.lastname@example.org.
Wir freuen uns auf Sie!
Tags: Labormitarbeiter, Medizinsch-technische Assistentin, MTLA, TA, Technische Assistentin,
New Laboratory method: DNA-PCR | January 27, 2016
DNA-PCR Test for Borrelia gets Increase in Speed and Sensitivity
From February 1st 2016, the BCA-lab will offer a new DNA-PCR test that delivers results faster to our clients and is more sensitive as compared to its predecessors.
The test will use blood or tissue/biopsy material to search for the most important species of Borrelia burgdorferi, including Borrelia miyamotoi and Bartonella spp.
The test for Borrelia is based on consecutive PCR reactions, which means that different pathogen genes can be detected on a highly specific and sensitive level. The repertoire of molecular biological detection at the BCA-lab is complemented by a PCR-based Bartonella-Assay.
The research team that developed this in-house PCR test method is led by Dr. Viktoria Krey (Molecular Biologist).
We are now able to produce results within 14 days of conducting the test; you can order the necessary test kits in our laboratory.
|phone:||+49 (0) 821 455 9820|
For more detailed questions please don’t hesitate to contact us on: email@example.com
Read more here!
Charity – 10 years BCA-clinic + BCA-lab | January 20, 2016
10 years of BCA-clinic + BCA-lab: 10 years of experience in the areas of therapy and diagnostics for tick-borne diseases.
Over 25,000 patients were treated in Augsburg since the clinic was founded in 2006.
Seven doctors work under Dr. Nicolaus’ direction, treating patients from all over the world.
Over 30 employees in the area of therapy, laboratory and research are working to improve therapy and diagnostics methods.
For this anniversary, we would like to support the precious work of patients’ organizations and associations in the task of informing and assisting other patients.
Click here to read more about how you can use this support.
Pour des informations en français, cliquez ici.
LymeSpot Revised: The new generation EliSpot | April 17, 2015
EliSpot is used to detect an infection of Borrelia and its co-infections on a cellular level. It is trustworthy and we have now been using it for several years. The first generation of enzymatic EliSpots determined the interferon-gamma production of cells and provided vital information about the infection. We have now developed this test even further.
The new EliSpot, ‘LymeSpot Revised’, delivers detailed information about the activity of the infection and/or inflammation. This test can better differentiate between an active (specific effector-cells) or latent (specific memory-cells) infection. As a result, it is now possible to evaluate whether it is an infection, inflammation or autoimmune processes that are prevailing. In comparison with EliSpot, which is based on the production of interferon-γ, LymeSpot also determines the levels of cytokine IL-2.
For more information, click here
On the 12th of February 2015, a new study was published that demonstrates the clinical benefits of the therapeutic approach by EliSpot Assay in identifying the two cytokines Gamma-Interferon and Interleukin-2 amongst patients with acute and chronic Q-fever. Q-fever is also a tick-borne disease. You can find this study here.